FIRM FIXED PRICENO SET ASIDE USED.
AVKARE LLC - NEW AWARD FOR METFORMIN HYDROCHLORIDE (HCL) 24HR SUSTAINED ACTION (SA) TABLETS PERIOD IS DECEMBER 30, 2025 - DECEMBER 29, 2026 WITH FOUR ONE-YEAR OPTIONS.
PIID: 36E79726D0002Solicitation ID: 36E79725R0051
Signed Date: Oct 30, 2025Effective Date: Dec 30, 2025
Vendor
AVKARE LLC
NAICS
325412
Signed Date
Oct 30, 2025
Key Details
Description
NEW AWARD FOR METFORMIN HYDROCHLORIDE (HCL) 24HR SUSTAINED ACTION (SA) TABLETS PERIOD IS DECEMBER 30, 2025 - DECEMBER 29, 2026 WITH FOUR ONE-YEAR OPTIONS.
Context & Analysis
On Oct 30, 2025, Department of Veterans Affairs to AVKARE LLC for new award for metformin hydrochloride (hcl) 24hr sustained action (sa) tablets period is december 30, 2025 - december 29, 2026 with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 2 offers received. The procurement used a NO SET ASIDE USED. set-aside.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.
Related
Agencies
Vendors